Paper36964229
Structural requirement of RARγ agonism through computational aspects.
Liu H and 9 others. J Mol Model, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Structural requirement of RARγ agonism through computational aspects. Papers, record 36964229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Dynamics Simulation | Major topic |
| Quantitative Structure-Activity Relationship | Major topic |
| Molecular Docking Simulation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant No. D20029 | Overseas Expertise Introduction Project for Discipline Innovation | PubMed | ||
| 2012520005 | Program for Innovative Talents of Higher Education of Liaoning | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31452096 | Integrating Molecular Docking and Molecular Dynamics Simulations. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/31452096 | PubMed |
| 2 | 33652835 | Trifarotene: A Current Review and Perspectives in Dermatology. | Biomedicines | 2021 | https://conductscience.org/library/papers/33652835 | PubMed |
| 3 | 34339839 | Nuclear receptors in liver fibrosis. | Biochim Biophys Acta Mol Basis Dis | 2021 | https://conductscience.org/library/papers/34339839 | PubMed |
| 4 | 20543827 | A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20543827 | PubMed |
| 5 | 15027865 | Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. | J Med Chem | 2004 | https://conductscience.org/library/papers/15027865 | PubMed |
| 6 | 32100454 | Selective RAR agonists for acne vulgaris: A narrative review. | J Cosmet Dermatol | 2020 | https://conductscience.org/library/papers/32100454 | PubMed |
| 7 | 25933005 | An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist. | PLoS One | 2015 | https://conductscience.org/library/papers/25933005 | PubMed |
| 8 | 31255985 | Role of Retinoic Acid Receptor-γ in DNA Damage-Induced Necroptosis. | iScience | 2019 | https://conductscience.org/library/papers/31255985 | PubMed |
| 9 | 35178333 | Binding free energy of protein/ligand complexes calculated using dissociation Parallel Cascade Selection Molecular Dynamics and Markov state model. | Biophys Physicobiol | 2021 | https://conductscience.org/library/papers/35178333 | PubMed |
| 10 | 30802558 | Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. | J Am Acad Dermatol | 2019 | https://conductscience.org/library/papers/30802558 | PubMed |
| 11 | 12220491 | C-H...O hydrogen bonds in the nuclear receptor RARgamma--a potential tool for drug selectivity. | Structure | 2002 | https://conductscience.org/library/papers/12220491 | PubMed |
| 12 | 33472949 | Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells. | Mol Cancer Res | 2021 | https://conductscience.org/library/papers/33472949 | PubMed |
| 13 | 10964567 | Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. | J Mol Biol | 2000 | https://conductscience.org/library/papers/10964567 | PubMed |
| 14 | 32854112 | A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. | Blood | 2021 | https://conductscience.org/library/papers/32854112 | PubMed |
| 15 | 29706423 | Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/29706423 | PubMed |
| 16 | 24962887 | Complexity of the RAR-mediated transcriptional regulatory programs. | Subcell Biochem | 2014 | https://conductscience.org/library/papers/24962887 | PubMed |
| 17 | 31694317 | Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations. | Cells | 2019 | https://conductscience.org/library/papers/31694317 | PubMed |
| 18 | 23579614 | Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. | J Comput Aided Mol Des | 2013 | https://conductscience.org/library/papers/23579614 | PubMed |
| 19 | 7501014 | Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. | Nature | 1995 | https://conductscience.org/library/papers/7501014 | PubMed |
| 20 | 10841540 | Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARgamma. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10841540 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42625115 | Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42625115 | PubMed |
| 41641227 | A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41641227 | PubMed |
| 38927935 | P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38927935 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RARG | 5916 | PubTator's text mining | https://conductscience.org/library/genes/5916 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36964229
GET https://conductscience.org/api/papers/v1/36964229/references?page=2